Africa’s TB Fight at a Crossroads: Historic Progress Meets Critical Funding Crisis
New WHO data reveals Africa has achieved the world’s most dramatic decline in tuberculosis, cutting deaths by 42% and cases by 24% since 2015 through improved detection and treatment. Yet this hard-won progress now faces collapse as treatment gaps persist and vital research funding vanishes.
Progress Under Threat
While South Africa, Mozambique and Zambia lead the continent in meeting WHO targets, Central and West Africa lag dangerously behind. The crisis deepens as U.S. cancels 300+ HIV/TB research grants to South African universities, exacerbating a funding shortfall where only $0.9 billion of the required $4.5 billion is available annually.
The Human Cost
Every unfunded TB program leaves families facing catastrophic health costs in a disease that still claims hundreds of thousands of African lives yearly. Experts warn that without urgent action to close diagnostic gaps and restore funding, Africa risks surrendering its TB control gains – with deadly consequences for global health security.
Key Takeaways:
- Africa proves TB progress possible with 42% fewer deaths
- Devastating research cuts threaten future breakthroughs
- 80% funding gap could reverse all hard-won gains
- Geographic inequalities leave millions vulnerable
We’re winning battles but could lose the war, warns one WHO official, as the continent’s TB success story now hangs in the balance.
No comment